Concepedia

Joelle Baddour

JB

Statistics

Publications

3

Citations

43

H-Index

3

Active since

2021

Affiliations

C4 Therapeutics (United States)(Current)

Joelle Baddour is an author at C4 Therapeutics (United States) specializing in oncogenic signaling pathways, protein targeting, and chemical biology.

ORCID

Publications per year

2021–2023

3

Publications

3

Development of an AchillesTAG degradation system and its application to control CAR-T activity

Gesine K. Veits, Christina S. Henderson, Abigail Vogelaar et al. · Current Research in Chemical Biology · 2021 · 21 citations · Full text

, , +10

Abstract 2158: Preclinical evaluation of CFT1946 as a selective degrader of mutant BRAF for the treatment of BRAF driven cancers

Mathew E. Sowa, Bridget Kreger, Joelle Baddour et al. · Cancer Research · 2022 · 12 citations

, , +16

Abstract 3425: The discovery and characterization of CFT1946: A potent, selective, and orally bioavailable degrader of mutant BRAF for the treatment of BRAF-driven cancers

Yanke Liang, Mathew E. Sowa, Katrina L. Jackson et al. · Cancer Research · 2023 · 10 citations

, , +15

1–3 of 3